Due to health issues, this site is no longer maintained and will be shut down shortly. |
Catalent Inc is a drug development, delivery and supply partner company. It engages in advanced delivery technologies and development solutions for drugs, biologics, and consumer health products across US, Europe and other international markets.
$67.42 +3.15 (4.90%)
As of 03/27/2023 14:09:29 EST IEX book CBOE book
2022 © Stock Market MBA, Inc.